1
|
Avolio R, Andreoli T, Ercolini C, Mignone W, Beltrame R, Razzuoli E, Modesto P, Zoppi S, Crescio MI, Ostorero F, Gili M, Abete MC, Meloni D, Dellepiane M. Retrospective data analysis of animal poisoning events in Liguria. Vet Anim Sci 2021; 13:100178. [PMID: 34151043 PMCID: PMC8188559 DOI: 10.1016/j.vas.2021.100178] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 05/15/2021] [Accepted: 05/20/2021] [Indexed: 11/15/2022] Open
Abstract
Confirmed animal poisoning cases were 215/497 (43.2%) from 2009 to 2018. Anticoagulant rodenticides (79.2%) were the main cause of animal poisoning. The most affected areas are located along the coast. Dogs and cats were 40.0% of confirmed animal poisoning.
Intentional poisoning represents a serious risk to domestic and wild animals, and it can be an environmental and human health issue as well . This paper is a retrospective study, which covers a decade, based on animal poisoning cases and poisoned baits that were submitted for diagnostic examinations to the Veterinary Medical Research Institute for Piedmont, Liguria and the Aosta Valley (IZS-PLVA) in Liguria region. All data were collected through a passive surveillance system introduced in Italy by a decree of the Ministry of Health in January 2009. 43.2% of the animal poisoning cases were confirmed by toxicological analysis, whereas toxic agents were detected in 31.1% of the baits. The most affected animal species were dogs and cats, followed by synanthropic birds,. Only 4% of the total poisoning events analysed involved wild animals and cases of livestock poisoning were minimal. An increased number of cases in January, March, April and August was noticed, but no seasonal trend was detected. The most affected areas were the ones with the highest level of urbanization and population density. The major cause of the poisonings and the most common substances detected in the examined baits were anticoagulants whereas cholinesterase inhibitors, organochlorine pesticides and carbamates were detected in a minor number of cases. This study raises concerns about deliberate animal poisoning in ligurian region and highlights the necessity to fight this phenomenon as it endangers animals, humans and environment.
Collapse
Affiliation(s)
- R Avolio
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - T Andreoli
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - C Ercolini
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - W Mignone
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - R Beltrame
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - E Razzuoli
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - P Modesto
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - S Zoppi
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - M I Crescio
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - F Ostorero
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - M Gili
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - M C Abete
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - D Meloni
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| | - M Dellepiane
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, Turin, 10154, Italy
| |
Collapse
|
2
|
Owens M, Watkins E, Bot M, Brouwer IA, Roca M, Kohls E, Penninx BWJH, Grootheest G, Hegerl U, Gili M, Visser M. Nutrition and depression: Summary of findings from the EU‐funded MooDFOOD depression prevention randomised controlled trial and a critical review of the literature. NUTR BULL 2020. [DOI: 10.1111/nbu.12447] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- M. Owens
- Department of Psychology University of Exeter Exeter UK
| | - E. Watkins
- Department of Psychology University of Exeter Exeter UK
| | - M. Bot
- Amsterdam UMC Vrije Universiteit, Psychiatry Amsterdam Public Health Research Institute GGZ in Geest Specialized Mental Health Care Amsterdam The Netherlands
| | - I. A. Brouwer
- Department of Health Sciences Faculty of Science Amsterdam Public Health Research Institute Vrije Universiteit Amsterdam Amsterdam The Netherlands
| | - M. Roca
- Institut Universitari d’ Investigació en Ciències de la Salut (IUNICS/IDISBA) Rediapp University of Balearic Islands Palma de Mallorca Spain
| | - E. Kohls
- Department of Psychiatry and Psychotherapy Medical Faculty University Leipzig Leipzig Germany
| | - B. W. J. H. Penninx
- Amsterdam UMC Vrije Universiteit, Psychiatry Amsterdam Public Health Research Institute GGZ in Geest Specialized Mental Health Care Amsterdam The Netherlands
| | - G. Grootheest
- Amsterdam UMC Vrije Universiteit, Psychiatry Amsterdam Public Health Research Institute GGZ in Geest Specialized Mental Health Care Amsterdam The Netherlands
| | - U. Hegerl
- Department of Psychiatry, Psychosomatics and Psychotherapy Goethe‐University Frankfurt Germany
| | - M. Gili
- Institut Universitari d’ Investigació en Ciències de la Salut (IUNICS/IDISBA) Rediapp University of Balearic Islands Palma de Mallorca Spain
| | - M. Visser
- Department of Health Sciences Faculty of Science Amsterdam Public Health Research Institute Vrije Universiteit Amsterdam Amsterdam The Netherlands
| | | |
Collapse
|
3
|
Soto-Sanz V, Castellví P, Piqueras JA, Rodríguez-Marín J, Rodríguez-Jiménez T, Miranda-Mendizábal A, Parés-Badell O, Almenara J, Alonso I, Blasco MJ, Cebrià A, Gabilondo A, Gili M, Lagares C, Roca M, Alonso J. Internalizing and externalizing symptoms and suicidal behaviour in young people: a systematic review and meta-analysis of longitudinal studies. Acta Psychiatr Scand 2019; 140:5-19. [PMID: 30980525 DOI: 10.1111/acps.13036] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/08/2019] [Indexed: 12/16/2022]
Abstract
OBJECTIVE To assess internalizing and externalizing symptoms as risk factors for suicidal behaviour and suicide among adolescents and young adults. METHOD We conducted a systematic review of articles published until January 2017. We identified 26 883 potential papers; 1701 full-text articles were assessed for eligibility, of which 1479 were excluded because of methodological reasons. Diverse meta-analyses were performed for each group of symptoms. Odds ratios (ORs) and 95% confidence intervals (95% CI) or beta coefficients for categorical variables, and effect size (ES) were calculated for continuous variables. RESULTS Finally, 41 studies were included, involving participants aged 12-26 years for a systematic review, and 24 articles were included for meta-analysis. The meta-analysis showed that youths with any internalizing (ES = 0.93) or externalizing symptoms (ES = 0.76 and OR = 2.59) were more likely to attempt suicide in future. This effect was also seen in depression symptoms (OR = 6.58 and ES = 1.00), legal problems (OR = 3.36), and anxiety (ES = 0.65). CONCLUSION Reported internalizing and externalizing symptoms are predictors of suicide behaviour in young people; therefore, the detection and management of these symptoms in young populations could be a crucial strategy for preventing suicidality in this group.
Collapse
Affiliation(s)
- V Soto-Sanz
- Department of Health Psychology, Miguel Hernandez University of Elche, Alicante, Spain
| | | | - J A Piqueras
- Department of Health Psychology, Miguel Hernandez University of Elche, Alicante, Spain
| | - J Rodríguez-Marín
- Department of Health Psychology, Miguel Hernandez University of Elche, Alicante, Spain
| | - T Rodríguez-Jiménez
- Department of Health Psychology, Miguel Hernandez University of Elche, Alicante, Spain.,Department of Psychology, Catholic University of Murcia, Murcia, Spain
| | - A Miranda-Mendizábal
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.,Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - O Parés-Badell
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - J Almenara
- Area of Preventive Medicine and Public Health, University of Cadiz, Cadiz, Spain
| | - I Alonso
- Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell, Spain
| | - M J Blasco
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.,Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.,CIBER Epidemiología, y Salud Pública (CIBERESP), Madrid, Spain
| | - A Cebrià
- Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell, Spain
| | - A Gabilondo
- Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, País Vasco, Spain.,Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute, San Sebastián, Spain
| | - M Gili
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain.,Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - C Lagares
- Department of Statistics and Operative Research, University of Cádiz, Cádiz, Spain
| | - M Roca
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain.,Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - J Alonso
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.,Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.,CIBER Epidemiología, y Salud Pública (CIBERESP), Madrid, Spain
| |
Collapse
|
4
|
Miranda-Mendizábal A, Castellví P, Parés-Badell O, Almenara J, Alonso I, Blasco MJ, Cebrià A, Gabilondo A, Gili M, Lagares C, Piqueras JA, Roca M, Rodríguez-Marín J, Rodríguez-Jiménez T, Soto-Sanz V, Vilagut G, Alonso J. Sexual orientation and suicidal behaviour in adolescents and young adults: systematic review and meta-analysis. Br J Psychiatry 2017; 211:77-87. [PMID: 28254960 DOI: 10.1192/bjp.bp.116.196345] [Citation(s) in RCA: 88] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Revised: 11/21/2016] [Accepted: 11/27/2016] [Indexed: 11/23/2022]
Abstract
BackgroundResearch suggests that lesbian, gay and bisexual (LGB) adolescents have a higher risk of suicidal behaviours than their heterosexual peers, but little is known about specific risk factors.AimsTo assess sexual orientation as a risk factor for suicidal behaviours, and to identify other risk factors among LGB adolescents and young adults.MethodA systematic search was made of six databases up to June 2015, including a grey literature search. Population-based longitudinal studies considering non-clinical populations aged 12-26 years and assessing being LGB as a risk factor for suicidal behaviour compared with being heterosexual, or evaluating risk factors for suicidal behaviour within LGB populations, were included. Random effect models were used in meta-analysis.ResultsSexual orientation was significantly associated with suicide attempts in adolescents and youths (OR = 2.26, 95% CI 1.60-3.20). Gay or bisexual men were more likely to report suicide attempts compared with heterosexual men (OR = 2.21, 95% CI 1.21-4.04). Based on two studies, a non-significant positive association was found between depression and suicide attempts in LGB groups.ConclusionsSexual orientation is associated with a higher risk of suicide attempt in young people. Further research is needed to assess completed suicide, and specific risk factors affecting the LGB population.
Collapse
Affiliation(s)
- A Miranda-Mendizábal
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - P Castellví
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - O Parés-Badell
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - J Almenara
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - I Alonso
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - M J Blasco
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - A Cebrià
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - A Gabilondo
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - M Gili
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - C Lagares
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - J A Piqueras
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - M Roca
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - J Rodríguez-Marín
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - T Rodríguez-Jiménez
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - V Soto-Sanz
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - G Vilagut
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| | - J Alonso
- A. Miranda-Mendizábal, MD, MPH, Health Services Research Group, Institut Hospital del Mar d'Investigacións Mèdiques (IMIM) and Department of Health and Experimental Sciences, Pompeu Fabra University (UPF), Barcelona; P. Castellví, PhD, Health Services Research Group, IMIM and Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona; O. Parés-Badell, MD, MPH, Health Services Research Group, IMIM, Barcelona; J. Almenara, MD, PhD, Faculty of Nursing and Physiotherapy, University of Cádiz; I. Alonso, PhD, Morales Meseguer Hospital, Murcia; M. J. Blasco, MSc, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona; A. Cebrià, PhD, Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell; A. Gabilondo, MD, PhD, Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, and Mental Health and Psychiatric Care Research Unit, BioDonosti Health Research Institute; M. Gili, PhD, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca; C. Lagares, PhD, Department of Statistics and Operative Research, University of Cádiz; J. A. Piqueras, PhD, Department of Health Psychology, Miguel Hernandez University of Elche; M. Roca, MD, PhD, IUNICS-IDISPA and Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca; J. Rodríguez-Marín, PhD, T. Rodríguez-Jiménez, PhD, v. Soto-Sanz, BSc, Department of Health Psychology, Miguel Hernandez University of Elche; G. Vilagut, Health Services Research Group, IMIM, and CIBERESP, Barcelona; Jordi Alonso, MD, PhD, Health Services Research Group, IMIM, Department of Health and Experimental Sciences, UPF, and CIBERESP, Barcelona, Spain
| |
Collapse
|
5
|
Castellví P, Lucas-Romero E, Miranda-Mendizábal A, Parés-Badell O, Almenara J, Alonso I, Blasco MJ, Cebrià A, Gabilondo A, Gili M, Lagares C, Piqueras JA, Roca M, Rodríguez-Marín J, Rodríguez-Jimenez T, Soto-Sanz V, Alonso J. Longitudinal association between self-injurious thoughts and behaviors and suicidal behavior in adolescents and young adults: A systematic review with meta-analysis. J Affect Disord 2017; 215:37-48. [PMID: 28315579 DOI: 10.1016/j.jad.2017.03.035] [Citation(s) in RCA: 127] [Impact Index Per Article: 18.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Revised: 01/09/2017] [Accepted: 03/10/2017] [Indexed: 01/04/2023]
Abstract
BACKGROUND Adolescents with previous self-injurious thoughts and behaviors (SITB) have over 2-fold risk of dying by suicide, higher than older ages. This meta-analysis aims to disentangle the association of each SITB with subsequent suicidal behavior in adolescence/young adulthood, the contribution of each SITB, and the proportion of suicide deaths with no previous suicide attempt. METHODS We searched 6 databases until June 2015. INCLUSION CRITERIA 1. Assessment of any previous SITB [a) suicidal thoughts and behaviors (ideation; threat/gesture; plan; attempt); b) non-suicidal thoughts and behaviors (thoughts; threat/gesture; self-injury); c) self-harm] as a risk factor of suicide attempt or suicide death; 2. Case-control or cohort studies; 3. Subjects aged 12-26y. Random effect models, metaregression analyses including mental health and environmental variables, and population attributable risks (PAR)s were estimated. RESULTS From 23,682 potentially eligible articles, 29 were included in the meta-analysis (1,122,054 individuals). While 68% of all youth suicide deaths had no previous suicide attempt, suicide death was very strongly associated with any previous SITB (OR=22.53, 95%CI: 18.40-27.58). Suicide attempts were also associated with a history of previous SITB (OR=3.48, 95%CI: 2.71-4.43). There were no moderating effects for mental health and environmental features. The PAR of previous SITB to suicide attempts is 26%. LIMITATIONS There is considerable heterogeneity between the available studies. Due to limitations in the original studies, an over-estimation of the proportion dying at their first attempt cannot be ruled out, since they might have missed unrecognized previous suicide attempts. CONCLUSIONS Although more than two thirds of suicide deaths in adolescence/young adulthood have occurred with no previous suicidal behavior, previous SITBs have a much higher risk of dying by suicide than previously reported in this age group.
Collapse
Affiliation(s)
- P Castellví
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain
| | - E Lucas-Romero
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - A Miranda-Mendizábal
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - O Parés-Badell
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - J Almenara
- Area of Preventive Medicine and Public Health. University of Cadiz, Spain
| | - I Alonso
- Morales Meseguer Hospital, Murcia, Spain
| | - M J Blasco
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - A Cebrià
- Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell, Spain
| | - A Gabilondo
- Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, Spain; Mental Health and Psychiatric Care Research Unit. BioDonosti Health Research Institute, Spain
| | - M Gili
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain; Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - C Lagares
- Department of Statistics and Operative Research. University of Cádiz. Spain
| | - J A Piqueras
- Department of Health Psychology, Miguel Hernandez University of Elche, Spain
| | - M Roca
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain; Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - J Rodríguez-Marín
- Department of Health Psychology, Miguel Hernandez University of Elche, Spain
| | - T Rodríguez-Jimenez
- Department of Health Psychology, Miguel Hernandez University of Elche, Spain
| | - V Soto-Sanz
- Department of Health Psychology, Miguel Hernandez University of Elche, Spain
| | - J Alonso
- Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
| |
Collapse
|
6
|
Castellví P, Miranda-Mendizábal A, Parés-Badell O, Almenara J, Alonso I, Blasco MJ, Cebrià A, Gabilondo A, Gili M, Lagares C, Piqueras JA, Roca M, Rodríguez-Marín J, Rodríguez-Jimenez T, Soto-Sanz V, Alonso J. Exposure to violence, a risk for suicide in youths and young adults. A meta-analysis of longitudinal studies. Acta Psychiatr Scand 2017; 135:195-211. [PMID: 27995627 DOI: 10.1111/acps.12679] [Citation(s) in RCA: 90] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/14/2016] [Indexed: 12/18/2022]
Abstract
OBJECTIVE To assess the association and magnitude of the effect of early exposure to different types of interpersonal violence (IPV) with suicide attempt and suicide death in youths and young adults. METHOD We searched six databases until June 2015. Inclusion criteria were as follows: (1) assessment of any type of IPV as risk factor of suicide attempt or suicide: (i) child maltreatment [childhood physical, sexual, emotional abuse, neglect], (ii) bullying, (iii) dating violence, and (iv) community violence; (2) population-based case-control or cohort studies; and (3) subjects aged 12-26 years. Random models were used for meta-analyses (Reg: CRD42013005775). RESULTS From 23 682 articles, 29 articles with 143 730 subjects for meta-analyses were included. For victims of any IPV, OR of subsequent suicide attempt was 1.99 (95% CI: 1.73-2.28); for child maltreatment, 2.25 (95% CI: 1.85-2.73); for bullying, 2.39 (95% CI: 1.89-3.01); for dating violence, 1.65 (95% CI: 1.40-1.94); and for community violence, 1.48 (95% CI: 1.16-1.87). Young victims of IPV had an OR of suicide death of 10.57 (95% CI: 4.46-25.07). CONCLUSION Early exposure to IPV confers a risk of suicide attempts and particularly suicide death in youths and young adults. Future research should address the effectiveness of preventing and detecting early any type of IPV exposure in early ages.
Collapse
Affiliation(s)
- P Castellví
- Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| | - A Miranda-Mendizábal
- Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - O Parés-Badell
- Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - J Almenara
- Area of Preventive Medicine and Public Health, University of Cadiz, Cadiz, Spain
| | - I Alonso
- Morales Meseguer Hospital, Murcia, Spain
| | - M J Blasco
- Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.,Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - A Cebrià
- Department of Mental Health, Corporació Sanitaria Parc Taulí, Sabadell, Spain
| | - A Gabilondo
- Outpatient Mental Health Care Network, Osakidetza-Basque Health Service, Donostia-San Sebastián, Spain.,Mental Health and Psychiatric Care Research Unit, BioDonostia Health Research Institute, Donostia-San Sebastián, Spain
| | - M Gili
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain.,Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - C Lagares
- Department of Statistics and Operative Research, University of Cádiz, Cádiz, Spain
| | - J A Piqueras
- Department of Health Psychology, Miguel Hernandez University of Elche, Elche, Spain
| | - M Roca
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands, Palma de Mallorca, Spain.,Network of Preventive Activities and Health Promotion, University of Balearic Islands, Palma de Mallorca, Spain
| | - J Rodríguez-Marín
- Department of Health Psychology, Miguel Hernandez University of Elche, Elche, Spain
| | - T Rodríguez-Jimenez
- Department of Health Psychology, Miguel Hernandez University of Elche, Elche, Spain
| | - V Soto-Sanz
- Department of Health Psychology, Miguel Hernandez University of Elche, Elche, Spain
| | - J Alonso
- Health Services Research Group, IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.,Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| |
Collapse
|
7
|
García-Toro M, Vicens-Pons E, Gili M, Roca M, Serrano-Ripoll MJ, Vives M, Leiva A, Yáñez AM, Bennasar-Veny M, Oliván-Blázquez B. Obesity, metabolic syndrome and Mediterranean diet: Impact on depression outcome. J Affect Disord 2016; 194:105-8. [PMID: 26807670 DOI: 10.1016/j.jad.2015.12.064] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2015] [Revised: 12/10/2015] [Accepted: 12/26/2015] [Indexed: 12/21/2022]
Abstract
OBJECTIVE Obesity, metabolic syndrome (MetS) and low adherence to Mediterranean diet are frequent in major depression patients and have been separately related with prognosis. The aim of this study is to analyse their predictive power on major depression outcome, at 6 and 12 months. METHODS 273 Major depressive patients completed the Beck Depression Inventory for depressive symptoms and the 14-item Mediterranean diet adherence score. MetS was diagnosed according to the International Diabetes Federation (IDF). RESULTS At the baseline Mediterranean diet adherence was inversely associated with depressive symptoms (p=0.007). Depression response was more likely in those patients with normal weight (p=0.006) and not MetS (p=0.013) but it was not associated with Mediterranean diet adherence (p=0.625). Those patients with MetS and obesity were less likely to improve symptoms of depression than patients with obesity but not MetS. CONCLUSIONS Obesity and MetS, but not low adherence to the Mediterranean diet at baseline, predicted a poor outcome of depression at 12 months. Our study suggests that MetS is the key factor that impacts negatively in depression prognosis, rather than obesity or diet. If this finding is confirmed, clinicians should be aware about MetS diagnosis and treatment in overweight depressed patients, especially if outcome is not being satisfactory enough.
Collapse
Affiliation(s)
- M García-Toro
- University of Balearic Islands, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - E Vicens-Pons
- Primary Care Prevention and Health Promotion Research Network, Spain; Psychiatric Service, Parc Sanitari Sant Joan de Déu, Barcelona, Spain
| | - M Gili
- University of Balearic Islands, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - M Roca
- University of Balearic Islands, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | | | - M Vives
- University of Balearic Islands, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - A Leiva
- Primary Care Research Unit of Mallorca, Health Services-IbSalut, Instituto de Investigación Sanitaria, Spain
| | - A M Yáñez
- Instituto de Investigación Sanitaria de Palma, IdISPa, Spain
| | - M Bennasar-Veny
- University of Balearic Islands, Spain; Department of Nursing, School of Nursing and Physiotherapy, University of Balearic Islands, Spain
| | - B Oliván-Blázquez
- Primary Care Prevention and Health Promotion Research Network, Spain; Department of Psychology and Sociology, University of Zaragoza, Spain
| |
Collapse
|
8
|
Serrano Ripoll MJ, Oliván-Blázquez B, Vicens-Pons E, Roca M, Gili M, Leiva A, García-Campayo J, Demarzo MP, García-Toro M. Lifestyle change recommendations in major depression: Do they work? J Affect Disord 2015; 183:221-8. [PMID: 26025368 DOI: 10.1016/j.jad.2015.04.059] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/03/2015] [Revised: 04/29/2015] [Accepted: 04/30/2015] [Indexed: 11/29/2022]
Abstract
BACKGROUND Modifying some lifestyle factors can be useful in depression, at least as an adjuvant treatment. Combining different lifestyle interventions seems to be an adequate strategy to increase their antidepressant efficacy according with preliminary studies, but this issue has not been enough investigated. METHODS The present study is a randomized, double-blinded, multicentre, two arm-parallel clinical trials, with a 12 month follow-up. The sample consisted of 273 Primary Care patients. Four combined hygienic-dietary written recommendations were given to the patients about diet, exercise, light exposure and sleep hygiene. RESULTS Both active and control interventions were associated with improvement on BDI (Beck Depression Inventory) scores. However, there were not statistically significant differences (7.0 vs. 7.6; p=0.594). LIMITATIONS We were unable to monitor whether patients carry out recommendations. Intervention could be too difficult to accomplish for depressed patients without enough support and supervision. CONCLUSIONS Just giving written lifestyle recommendations are not enough for depressive patients to benefit from them, so perhaps lifestyle change recommendations work or do not work on Depression depending on how they are presented to patients and on monitoring systems of their implementation.
Collapse
Affiliation(s)
- M J Serrano Ripoll
- University of Balearic Islands, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Palma, Spain
| | - B Oliván-Blázquez
- Department of Psychology and Sociology, University of Zaragoza, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - E Vicens-Pons
- Primary Care Prevention and Health Promotion Research Network, Spain; Psychiatric Service, Parc Sanitari Sant Joan de Déu, Barcelona, Spain
| | - M Roca
- University of Balearic Islands, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Palma, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - M Gili
- University of Balearic Islands, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Palma, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - A Leiva
- Primary Care Research Unit of Mallorca, Health Services-IbSalut, Instituto de Investigación Sanitaria, Spain
| | - J García-Campayo
- Department of Psychology and Sociology, University of Zaragoza, Spain; Primary Care Prevention and Health Promotion Research Network, Spain
| | - M P Demarzo
- "Mente Aberta" - Brazilian Center for Mindfulness and Health Promotion, Federal University of Sao Paulo, UNIFESP, Brazil
| | - M García-Toro
- University of Balearic Islands, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Palma, Spain; Primary Care Prevention and Health Promotion Research Network, Spain.
| |
Collapse
|
9
|
Togliatto G, Dentelli P, Gili M, Gallo S, Deregibus C, Biglieri E, Iavello A, Santini E, Rossi C, Solini A, Camussi G, Brizzi MF. Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications. Int J Obes (Lond) 2015; 40:102-11. [PMID: 26122028 PMCID: PMC4722244 DOI: 10.1038/ijo.2015.123] [Citation(s) in RCA: 86] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2015] [Revised: 05/18/2015] [Accepted: 06/22/2015] [Indexed: 12/17/2022]
Abstract
BACKGROUND/OBJECTIVES Soluble factors and cell-derived extracellular vesicles (EVs) are crucial tissue repair mediators in cell-based therapy. In the present study, we investigate the therapeutic impact of EVs released by adipose tissue-derived stem cells (ASCs) recovered from obese subjects' visceral and subcutaneous tissues. METHODS ASCs were recovered from 10 obese (oASCs) and 6 non-obese (nASCs) participants and characterized. In selected experiments, nASCs and oASCs were cultured with palmitic acid (PA) or high glucose (HG), respectively. EVs from obese (oEVs) and non-obese (nEVs) subjects' visceral and subcutaneous ASCs were collected after ultracentrifugation and analyzed for their cargo: microRNA-126 (miR-126), vascular endothelial growth factor (VEGF), and matrix metalloproteinase 2 (MMP-2), and for their biological effects on endothelial cells (ECs). Western blotting analysis and loss- and gain-of function experiments were performed. RESULTS oEVs show impaired angiogenic potential compared with nEVs. This effect depends on EV cargo: reduced content of VEGF, MMP-2 and, more importantly, miR-126. We demonstrate, using gain- and loss-of-function experiments, that this reduced miR-126 content leads to Spred1 upregulation and the inhibition of the extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway in ECs. We also show that PA treatment of nASCs translates into the release of EVs that recapitulate oEV cargo. Moreover, HG treatment of oASCs further reduces miR-126 EV content and EV-mediated in vitro angiogenesis. Finally, impaired pro-angiogenic potential is also detected in EVs released from obese subcutaneous adipose tissue-derived ASCs. CONCLUSIONS These results indicate that obesity impacts on EV pro-angiogenic potential and may raise concerns about the use of adipose tissue-derived EVs in cell-based therapy in the obese setting.
Collapse
Affiliation(s)
- G Togliatto
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - P Dentelli
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - M Gili
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - S Gallo
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - C Deregibus
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - E Biglieri
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - A Iavello
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - E Santini
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - C Rossi
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - A Solini
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - G Camussi
- Department of Medical Sciences, University of Torino, Torino, Italy
| | - M F Brizzi
- Department of Medical Sciences, University of Torino, Torino, Italy
| |
Collapse
|
10
|
Vicens C, Bejarano F, Sempere E, Mateu C, Fiol F, Socias I, Aragonès E, Palop V, Beltran JL, Piñol JL, Lera G, Folch S, Mengual M, Basora J, Esteva M, Llobera J, Roca M, Gili M, Leiva A. Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care. Br J Psychiatry 2014; 204:471-9. [PMID: 24526745 DOI: 10.1192/bjp.bp.113.134650] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
BACKGROUND Benzodiazepines are extensively used in primary care, but their long-term use is associated with adverse health outcomes and dependence. AIMS To analyse the efficacy of two structured interventions in primary care to enable patients to discontinue long-term benzodiazepine use. METHOD A multicentre three-arm cluster randomised controlled trial was conducted, with randomisation at general practitioner level (trial registration ISRCTN13024375). A total of 532 patients taking benzodiazepines for at least 6 months participated. After all patients were included, general practitioners were randomly allocated (1:1:1) to usual care, a structured intervention with follow-up visits (SIF) or a structured intervention with written instructions (SIW). The primary end-point was the last month self-declared benzodiazepine discontinuation confirmed by prescription claims at 12 months. RESULTS At 12 months, 76 of 168 (45%) patients in the SIW group and 86 of 191 (45%) in the SIF group had discontinued benzodiazepine use compared with 26 of 173 (15%) in the control group. After adjusting by cluster, the relative risks for benzodiazepine discontinuation were 3.01 (95% CI 2.03-4.46, P<0.0001) in the SIW and 3.00 (95% CI 2.04-4.40, P<0.0001) in the SIF group. The most frequently reported withdrawal symptoms were insomnia, anxiety and irritability. CONCLUSIONS Both interventions led to significant reductions in long-term benzodiazepine use in patients without severe comorbidity. A structured intervention with a written individualised stepped-dose reduction is less time-consuming and as effective in primary care as a more complex intervention involving follow-up visits.
Collapse
Affiliation(s)
- C Vicens
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - F Bejarano
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - E Sempere
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - C Mateu
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - F Fiol
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - I Socias
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - E Aragonès
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - V Palop
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - J L Beltran
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - J L Piñol
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - G Lera
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - S Folch
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - M Mengual
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - J Basora
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - M Esteva
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - J Llobera
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - M Roca
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - M Gili
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| | - A Leiva
- Caterina Vicens, PhD, Balearic Health Service Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Ferran Bejarano, Catalunya Health Services, Reus, DAP Tarragona-Terres del l'Ebre; Ermengol Sempere, PhD, Valencia Health Services, Paterna Health Care Centre, Paterna, Valencia; Catalina Mateu, Francisca Fiol, Balearic Health Service, Son Serra-La Vileta Health Care Centre, Palma de Mallorca; Isabel Socias, Balearic Health Service, Manacor Health Care Centre, Palma de Mallorca; Enric Aragonès, PhD, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Vicente Palop, PhD, Valencia Health Services, La Ribera Hospital, Valencia; Jose Luis Beltran, Valencia Health Services, Altabix Health Care Centre, Alicante, Valencia; Josep Lluís Piñol, PhD, Catalunya Health Services, Primary Care Research Unit, Reus-Altebrat, Tarragona; Guillem Lera, Valencia Health Services, La Ribera Hospital, Valencia; Silvia Folch, Catalunya Health Services, Constantí Health Care Centre, Tarragona; Marta Mengual, Catalunya Health Services, Falset Health Care Centre, Tarragona; Josep Basora, Catalunya Health Services, Reus Health Care Centre, Tarragona; Magdalena Esteva, PhD, Joan Llobera, PhD, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca; Miguel Roca, PhD, Margalida Gili, PhD, Balearic Islands University, University Institute of Health and Science Research, Palma de Mallorca; Alfonso Leiva, MSc, Balearic Health Service, Primary Care Research Unit of Mallorca, Palma de Mallorca, Spain
| |
Collapse
|
11
|
Roca M, Gili M, Garcia-Campayo J, Armengol S, Bauza N, García-Toro M. Stressful life events severity in patients with first and recurrent depressive episodes. Soc Psychiatry Psychiatr Epidemiol 2013; 48:1963-9. [PMID: 23603934 DOI: 10.1007/s00127-013-0691-1] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2012] [Accepted: 04/09/2013] [Indexed: 11/28/2022]
Abstract
BACKGROUND Stressful life events are associated with depression and their role in first onset and recurrences is a promising but controversial perspective of research. The objective is to analyze the role of number of previous episodes and life events exposure in a large sample of primary care depressive patients taking into account life events severity. METHOD 10,257 patients with DSM-IV criteria for a current single or recurrent major depressive episode were recruited by 2,056 general practitioners in a cross-sectional epidemiological study. Patients answered the Montgomery-Asberg Depression Rating Scale, the Patient Health Questionnaire and the Social Readjustment Rating Scale (SRRS). Stressful life events were categorized into three levels of severity (severe, moderate and mild). All relevant confounding variables were analyzed: age, gender, depression severity, somatic symptoms severity and length of episode. RESULTS We found a significant positive correlation with number of episodes and depression severity. There was no significant correlation of SRRS scores with age, gender and length of episode. ANOVA exploring life events severity with regard to number of episodes showed statistically differences in SRRS total score, moderate life events and mild life events (F = 15.14, p < 0.001) but not for severe life events. CONCLUSIONS Prevention and treatment strategies for recurrent depression need to manage life stressful events during mild and long-term periods and not just in the initial recurrences of the disease.
Collapse
Affiliation(s)
- M Roca
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), University of Balearic Islands, Carretera de Valldemossa km 7.5, 07071, Palma de Mallorca, Spain,
| | | | | | | | | | | |
Collapse
|
12
|
Gili M, Roca M, Stuckler D, Basu S, McKee M. 2255 – The mental health risks economic crisis in spain: evidence from primary care centres, 2006 and 2010. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)77118-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
13
|
Dentelli P, Barale C, Togliatto G, Trombetta A, Olgasi C, Gili M, Riganti C, Toppino M, Brizzi MF. A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells. Diabetologia 2013; 56:173-84. [PMID: 23064289 DOI: 10.1007/s00125-012-2734-7] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2012] [Accepted: 08/30/2012] [Indexed: 01/31/2023]
Abstract
AIMS/HYPOTHESIS Successful outcomes have been obtained by exploiting adipose-derived stem cells (ASCs) in regenerative medicine. NADPH oxidase (NOX)-generated reactive oxygen species (ROS) are known to control stem cell self-renewal. Several high glucose (HG)-mediated effects depend on NOX-generated ROS. In this study, we investigated whether, and how mechanistically, HG concentrations control ASC fate in patients with diabetes. METHODS ASCs from the visceral adipose tissue of non-diabetic (N-ASCs) and diabetic participants (D-ASCs), identified by surface markers, were counted and evaluated for ROS generation and stem cell properties. Their ability to release soluble factors was assessed by BioPlex analysis. To reproduce an in vitro diabetic glucose milieu, N-ASCs were cultured in HG (25 mmol/l) or normal glucose (NG) concentration (5 mmol/l), as control. ASC pluripotency was assessed by in vitro study. The p47(phox) NOX subunit, AKT and octamer-binding transcription factor 4 (OCT4; also known as POU5F1) were knocked down by small-interfering RNA technology. Stem-cell features were evaluated by sphere cluster formation. RESULTS The ASC number was higher in diabetic patients than in non-diabetic controls. Production of OCT4 and NANOG, stem-cell-specific transcription factors, was upregulated in D-ASCs compared with N-ASCs. Moreover, we found that ROS production and AKT activation drove D-ASC, but not N-ASC, secretion. When N-ASCs were cultured in vitro in the presence of HG, they also expressed OCT4/NANOG and formed spheres. By knock-down of the p47(phox) NOX subunit, AKT and OCT4 we demonstrated that NOX-generated ROS and their downstream signals are crucial for HG-mediated ASC de-differentiation and proinflammatory cytokine production. CONCLUSIONS/INTERPRETATION We herein provide a rationale for exploiting D-ASCs in regenerative medicine and/or exploiting HG preconditioning to increase ASCs ex vivo.
Collapse
Affiliation(s)
- P Dentelli
- Department of Medical Sciences, University of Torino, Corso Dogliotti 14, 10126 Torino, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Gramaglia M, Gili M, Dalla Mutta M, Marello G, Mastrodomenico M, Bianchi D, Decastelli L. M1 AFLATOXIN IN RAW MILK AT VENDING MACHINE. Ital J Food Saf 2012. [DOI: 10.4081/ijfs.2012.3.79] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
15
|
Gili M, Garcia-Toro M, Vives M, Armengol S, Garcia-Campayo J, Soriano JB, Roca M. Medical comorbidity in recurrent versus first-episode depressive patients. Acta Psychiatr Scand 2011; 123:220-7. [PMID: 21118188 DOI: 10.1111/j.1600-0447.2010.01646.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
OBJECTIVE This study compares the comorbidity of affective disorders and medical diseases in primary care patients with either a first or recurrent depressive episode. METHOD A cross-sectional epidemiological study in primary care centres in Spain was designed. A total of 10,257 primary care patients suffering a DSM-IV major depressive episode (MDD) were analysed. Depression was assessed using the Montgomery-Asberg Depression Rating Scale (MADRS), and World Health Organization (WHO) medical diagnoses were provided by the patient's general practitioner according to medical records revised on the basis of radiology or laboratory test data. RESULTS A total of 88.6% of recurrent patients and 71.1% of first-episode depressive patients reported a medical condition (aOR = 2.61, CI = 2.31-2.93). All medical conditions were more prevalent in the recurrent group than in first-episode group, and with the exception of myocardial infarction, psoriasis and migraine, all other crude ORs showed statistically significant differences between first- and recurrent episodes patients after adjusting for gender, age, education, socioeconomic status and body mass index (BMI). CONCLUSION Recurrent depression is associated with a decrement in health that is significantly greater than in first-episode depression. Special attention needs to be paid to the physical health in the middle- and long-term management of patients with affective disorders.
Collapse
Affiliation(s)
- M Gili
- Institut Universitari d'Investigació en Ciències de Salut, University of Balearic Islands, Palma de Mallorca, Spain.
| | | | | | | | | | | | | |
Collapse
|
16
|
García-Campayo J, Rodero B, del Hoyo YL, Luciano JV, Alda M, Gili M. Validation of a Spanish language version of the pain self-perception scale in patients with fibromyalgia. BMC Musculoskelet Disord 2010; 11:255. [PMID: 21050485 PMCID: PMC2991283 DOI: 10.1186/1471-2474-11-255] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2010] [Accepted: 11/04/2010] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The Pain Self-Perception Scale (PSPS) is a 24-item questionnaire used to assess mental defeat in chronic pain patients. The aim of this study was to develop a Spanish language version of the PSPS (PSPS-Spanish), to assess the instrument's psychometric properties in a sample of patients with fibromyalgia and to confirm a possible overlapping between mental defeat and pain catastrophizing. METHODS The PSPS was translated into Spanish by three bilingual content and linguistic experts, and then back-translated into English to assess for equivalence. The final Spanish version was administered, along with the Hospital Anxiety Depression Scale (HADS), Pain Visual Analogue Scale (PVAS), Pain Catastrophizing Scale (PCS) and Fibromyalgia Impact Questionnaire (FIQ), to 250 Spanish patients with fibromyalgia. RESULTS PSPS-Spanish was found to have high internal consistency (Cronbach's α = 0.90 and the item-total r correlation coefficients ranged between 0.68 and 0.86). Principal components analysis revealed a one-factor structure which explained 61.4% of the variance. The test-retest correlation assessed with the intraclass correlation coefficient, over a 1-2 weeks interval, was 0.78. The total PSPS score was significantly correlated with all the questionnaires assessed (HADS, PVAS, PCS, and FIQ). CONCLUSIONS The Spanish version of the PSPS appears to be a valid tool in assessing mental defeat in patients with fibromyalgia. In patients with fibromyalgia and Post-Traumatic Stress Disorder (PTSD), PSPS-Spanish correlates more intensely with FIQ than in patients without PTSD. Mental defeat seems to be a psychological construct different to pain catastrophizing.
Collapse
Affiliation(s)
- J García-Campayo
- Department of Psychiatry, Miguel Servet University Hospital, Instituto Aragonés de Ciencias de la Salud, University of Zaragoza, Spain
| | | | | | | | | | | |
Collapse
|
17
|
Béjar L, Gili M, Ramírez G, López J, Cabanillas JL. Dietary changes and colorectal cancer trends in Spain during 1951-2007. Rev esp enferm dig 2010; 102:159-68. [DOI: 10.4321/s1130-01082010000300002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
18
|
Roca M, Gili M, Garcia-Garcia M, Salva J, Vives M, Garcia Campayo J, Comas A. Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord 2009; 119:52-8. [PMID: 19361865 DOI: 10.1016/j.jad.2009.03.014] [Citation(s) in RCA: 195] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2009] [Revised: 03/16/2009] [Accepted: 03/16/2009] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To estimate the prevalence and comorbidity of the most common mental disorders in primary care practice in Spain, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) questionnaire. DESIGN A systematic sample of 7936 adult primary care patients was recruited by 1925 general practitioners in a large cross-sectional national epidemiological study. The PRIME-MD was used to diagnose psychiatric disorders. SETTING 1356 primary care units proportionally distributed throughout the country. RESULTS 53.6% of the sample presented one or more psychiatric disorder. The most prevalent were affective (35.8%), anxiety (25.6%), and somatoform (28.8%) disorders. 30.3% of the patients had more than one current mental disorder. 11.5% presented comorbidity between affective, anxiety, and somatoform disorders. CONCLUSIONS The study provides further evidence of the high prevalence and high comorbidity of mental disorders in primary care. Given the large overlap between affective, anxiety and somatoform disorders, future diagnostic classifications should reconsider the current separation between these entities.
Collapse
Affiliation(s)
- M Roca
- Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Juan March Hospital, University of Balearic Islands, Red de Investigación de Actividades Preventivas y Promoción de la Salud (RedIAPP), Palma de Mallorca, Spain.
| | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
BACKGROUND The aim of this paper is to analyse breast cancer mortality in Andalucia (Spain) between 1975 and 1999 based on age-period-cohort. PATIENTS AND METHODS Mortality data were obtained from the Mortality Registry of Andalucia. Deaths and population were divided into 13 age groups and five 5-year periods. From this, age-specific mortality rates for 17 birth cohorts were computed. These were plotted and fitted to Poisson regression models to assess age, period and cohort effects. RESULTS The best fit was found for the complete model, which simultaneously considered the effects of age-period-cohort. Cohort effects were found to be more important than period effects in terms of model fit. CONCLUSION These effects were manifest as a seemingly consistent increase in the relative risk of breast cancer mortality with a three-fold increase in women born in the 1950s relative to those born in the 1890s.
Collapse
Affiliation(s)
- A Cayuela
- Supportive Research Unit, Virgen del Rocío Hospital, Seville, Spain.
| | | | | | | |
Collapse
|
20
|
Abstract
OBJECTIVES To assess the success rate of pressure support ventilation (PSV) in acute lung injury patients undergoing continuous positive pressure ventilation (CPPV), to study physiologic changes after the transition from CPPV to PSV, and to investigate differences between patients who succeed and patients who fail PSV according to predetermined criteria. DESIGN Observational study. SETTING General intensive care unit in a teaching hospital. SUBJECTS We studied 48 patients having acute lung injury, as defined by a PaO2/F(IO2) <300 mm Hg and the presence of bilateral infiltrates on chest radiograph, and ventilated with CPPV. We included patients with PaO2 >80 mm Hg, at positive end-expiratory pressure of <15 cm H2O and with F(IO2) up to 1.0. INTERVENTIONS After enrollment, PSV was instituted and patients were strictly monitored during the following 48 hrs. Subjects who met any of the predefined PSV failure criteria during this period were returned to CPPV (Group F). PSV was continued in the remaining patients (Group S). MEASUREMENTS AND MAIN RESULTS Gas exchange, respiratory mechanics, and hemodynamics measurements were collected before switching from CPPV to PSV and were repeated at 24 hrs after beginning PSV, or immediately before return to CPPV in Group F patients. The physiologic deadspace volume to tidal volume ratio (V(D)/V(T)) was obtained by the Enghoff's equation from the measurement of the mixed expired CO2 fraction. PSV resulted in a significant PaCO2 decrease (49.2+/-10.9 mm Hg to 44.4+/-7.2 mm Hg) and significant increases in minute volume (V(E))(9.0+/-2.3 L/min to 12.0+/-4.0 L/min) and arterial blood pH (7.405+/-0.054 to 7.435+/-0.064), with stable oxygenation and hemodynamics. In patients who were hypercapnic (PaCO2 >50 mm Hg) during CPPV, the V(E) increase was higher than in normocapnic patients. In the latter patients, PaCO2 and pH did not change significantly going from CPPV to PSV. A total of 38 patients (79%) were allocated to Group S and the remaining 10 patients were included in Group F. In Group S, positive endexpiratory pressure of 9.4+/-2.9 cm H2O (range, 3-14 cm H2O) and a PSV level of 14.9+/-3.8 cm H2O (range, 9-22 cm H2O) were applied. In Group F, positive end-expiratory pressure of 8.9+/-3.1 cm H2O (range, 5-15 cm H2O) and a PSV level of 21.6+/-4.6 cm H2O (range, 16-31 cm H2O) were adopted. Compared with Group S, Group F had a longer duration of intubation (20.2+/-19.2 days vs. 9.2+/-13.5 days), a lower static compliance of the respiratory system (30.4+/-16.5 mL/cm H2O vs. 41.7+/-15.0 mL/cm H2O), and a higher V(D)/V(T) (0.70+/-0.09 vs. 0.52+/-0.10), but similar oxygenation and positive end-expiratory pressure. V(E) was higher in Group F during both CPPV and PSV. CONCLUSIONS In a relatively high proportion of the investigated patients, PSV was successful. The institution of PSV led to no major changes in oxygenation or in hemodynamics. PSV was associated with increases in V(E) and respiratory frequency. In patients who had been hypercapnic during CPPV, PaCO2 decreased despite a compensated pH. Compared with PSV success patients, patients who failed PSV appeared to be sicker, as shown by the higher duration of respiratory support, increased ventilatory needs, and decreased respiratory system compliance, despite similar arterial oxygenation and positive end-expiratory pressure.
Collapse
Affiliation(s)
- M Cereda
- Department of Anesthesia and Intensive Care, Ospedale S. Gerardo, Monza, Italy
| | | | | | | | | | | | | |
Collapse
|
21
|
Roca M, Gili M, Ferrer V, Bernardo M, Montaño JJ, Salvà JJ, Flores I, Leal S. Mental disorders on the island of Formentera: prevalence in general population using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Soc Psychiatry Psychiatr Epidemiol 1999; 34:410-5. [PMID: 10501710 DOI: 10.1007/s001270050162] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
BACKGROUND The aims of this two-stage epidemiological study were: to determine the prevalence of psychiatric disorders in the general population of the island of Formentera (Balearic Isles, Spain); to provide reference data for subsequent health care planning; and to test a relatively new assessment instrument, the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), in a community study. METHOD It was designed as a cross-sectional two-stage community study using the General Health Questionnaire (GHQ-28) at stage one (N = 697), and the SCAN at stage two (N = 242). RESULTS Estimated prevalence of disorders was 21.4% according to the ICD-10 classification system. Neurotic and somatoform disorders were the most prevalent, followed by substance-related, sleep and mood disorders. Total prevalence of mental disorders showed no significant differences according to sex. As regards age, mood and anxiety disorders were most prevalent in the 30- to 50-year age group, and sleep disorders were more prevalent in the older group. CONCLUSION Prevalences of mental disorders in Formentera are higher than those found in two-stage studies in other countries and similar to those found in most studies in Spain, despite the variety of the instruments used.
Collapse
Affiliation(s)
- M Roca
- Psychiatry and Social Psychology Unit, Departament of Psychology, University of the Balearic Isles, Carretera de Valldemossa km 7.5, E-07071 Palma de Mallorca, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Gili M, Ferrer V, Roca M, Bernardo M. [Gender differences in mental health: epidemiological study in the general population of the island of Formentera]. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1998; 26:90-96. [PMID: 9595822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The epidemiological data of prevalence of mental disorders according to gender differences are controversial. We analysed the prevalence among men and women via a two-stage epidemiological community study using the GHQ-28 and the SCAN on the island of Formentera (Spain). There are no sex differences in total prevalence; nevertheless some significant differences are detected when data is analysed on specific disorders. Affective disorders, sleep disorders and neurotic and somatoform disorders are more prevalent among women, whereas men have more psychoactive substance use disorders. Comorbidity with medical illness are higher in women but differences are not significant. These findings suggest the need to standardise procedures and instruments in these kinds of studies. This is because one of the bias could be the difference in the number of disorders included in the instrument design used (in our study, sleep disorders and psychoactive substance use disorders were included and personality disorders were excluded.
Collapse
Affiliation(s)
- M Gili
- Departamento de Psicología, Universitat de les Illes Balears, Palma de Mallorca
| | | | | | | |
Collapse
|
23
|
Rocha JL, Gentil MA, Gili M, Gil L, Cabello V, Bernal G. Continuous intravenous intradialysis versus intravenous postdialysis erythropoietin therapy in chronic haemodialysis patients: a randomized, controlled, crossover study. Nephrol Dial Transplant 1998; 13:89-92. [PMID: 9481721 DOI: 10.1093/ndt/13.1.89] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Subcutaneous recombinant human erythropoietin seems to be more effective than intravenous administration. Local pain, however, may diminish patient compliance with the subcutaneous route. Recently continuous intravenous intradialysis administration of rHuEpo has been reported to be more efficacious in stimulating erythropoiesis than the usual postdialysis intravenous bolus. METHODS We conducted a randomized, controlled, crossover study on stable chronic haemodialysis patients to compare the efficacy of continuous intradialysis rHuEpo therapy with intravenous postdialysis administration. Twenty patients were selected and randomly assigned to receive rHuEpo either postdialysis (control phase) or by continuous intradialysis perfusion (slow Epo phase) for 12 weeks. After this period, patients were switched to the alternative method for 12 additional weeks. The erythropoietin dose remained unchanged during the study. Haematocrit was monitored weekly and iron metabolism, serum Epo, and vitamins were measured monthly. Urea kinetics and iPTH measurements were performed every 3 months. RESULTS Three patients were excluded because of unrelated problems. The final mean haematocrit was unchanged from previous basal values in both phases and no statistical differences were found for any parameter between the groups. No differences were found in iron metabolism nor in urea kinetic parameters. CONCLUSIONS Continuous intravenous intradialysis administration of rHuEpo is not more effective than an intravenous postdialysis bolus as rHuEpo maintenance therapy in stable chronic haemodialysis patients.
Collapse
Affiliation(s)
- J L Rocha
- Division of Nephrology, Virgen del Rocío University Hospital, Seville, Spain
| | | | | | | | | | | |
Collapse
|
24
|
Antiñolo G, Borrego S, Gili M, Dapena J, Alfageme I, Reina F. Genotype-phenotype relationship in 12 patients carrying cystic fibrosis mutation R334W. J Med Genet 1997; 34:89-91. [PMID: 9039981 PMCID: PMC1050858 DOI: 10.1136/jmg.34.2.89] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
We present a phenotype-genotype correlation analysis in 12 patients with cystic fibrosis (CF) carrying the mutation R334W in the CFTR gene. The clinical data obtained for this group were compared with the clinical data of deltaF508/deltaF508 patients. Current age and age at diagnosis were significantly higher in the R334W mutation group (p=0.028 and p=0.0001). We found a lower rate of Pseudomonas aeruginosa colonisation in patients carrying the R334W mutation, although the difference was not found to be statistically significant. However, we found a statistically significant higher age of onset of Pseudomonas aeruginosa colonisation (p=0.0036) in the group of patients with the R334W mutation. Thirty three percent of R334W patients were pancreatic insufficient, significantly lower than the deltaF508/deltaF508 patients (p=0.004). We also found that the weight expressed as a percentage of ideal weight for height was significantly higher in patients with the R334W mutation (p=0.0028).
Collapse
Affiliation(s)
- G Antiñolo
- Unidad de Genética Médica, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | | | | | | | | | | |
Collapse
|
25
|
Viladiu P, Bosch FX, Castellsagué X, Muñoz N, Escribà JM, Hamsíkova E, Hofmannova V, Guerrero E, Izquierdo A, Navarro C, Moreo P, Izarzugaza I, Ascunce N, Gili M, Muñoz MT, Tafur L, Shah KV, Vonka V. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol 1997; 15:610-9. [PMID: 9053484 DOI: 10.1200/jco.1997.15.2.610] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
PURPOSE To assess whether human papillomavirus (HPV) DNA detection in cervical cancer specimens, or antibodies to selected HPV 16 peptides are predictors of tumor recurrence and long-term survival in patients with squamous cell invasive cervical cancer. SUBJECTS AND METHODS Four hundred seventy-one cases included in two population-based case-control studies underwent follow-up evaluation. The survival and cause of death were ascertained for 410 cases (87%), with a median follow-up time of 4.6 years after diagnosis. HPV DNA was assessed using an L1 polymerase chain reaction (PCR)-based system and Southern hybridization (SH) on scraped cytologic specimens or biopsies. HPV 16 antibodies to E2, L2, and E7 peptides were detected with enzyme-linked immunosorbent assay (ELISA). RESULTS Clinical stage was the only independent prognostic factor for recurrence or survival. Although seropositivity to HPV 16 E7/3 peptide predicted a twofold excess risk of mortality (adjusted hazards ratio [HRa] = 2.0; 95% confidence interval [CI], 1.2 to 3.3), the association was restricted to stage I (HRa = 6.6; 95% CI, 1.2 to 37.6) and II (HRa = 5.9; 95% CI, 2.1 to 16.5) patients. The presence of HPV DNA (HRa = 0.9; 95% CI, 0.5 to 1.5), different estimates of the HPV viral load and the HPV type identified were not predictors of tumor recurrence or survival. CONCLUSION The presence of antibodies to HPV 16 E7 proteins is of prognostic value in early-stage cervical cancer. Our results provide strong evidence that detection and typing of HPV DNA in cervical cells or tissues is not a prognostic factor for recurrence or survival.
Collapse
Affiliation(s)
- P Viladiu
- Institut Catala d'Oncologia, Servei d'Epidemiologia i Registre del Cáncer, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
de Sanjosé S, Bosch FX, Muñoz N, Tafur L, Gili M, Izarzugaza I, Izquierdo A, Navarro C, Vergara A, Muñoz MT, Ascunce N, Shah KV. Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health 1996; 86:1532-8. [PMID: 8916516 PMCID: PMC1380685 DOI: 10.2105/ajph.86.11.1532] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVES This study examined the causes of socioeconomic differences in invasive cervical cancer in two countries that differ substantially in cervical cancer incidence and economic development. METHODS Data were derived from two case-control studies carried out in Spain and Colombia; there were 373 case subjects, 387 control subjects, and 425 husbands interviewed with a structured questionnaire. Exfoliated cells were obtained from cervical or penile scrapes and tested for human papillomavirus (HPV) DNA. RESULTS Relative to better educated women, women with low educational levels in both countries reported fewer Pap smears and had a higher prevalence of HPV DNA. The prevalence ratio of HPV DNA across educational strata was twofold in Spain and fourfold in Colombia. In both countries, husbands of poorly educated women reported higher use of prostitutes than husbands of better educated women. In Colombia, 30% of husbands of poorly educated women harbored HPV DNA, compared with 10% of husbands of better educated women. CONCLUSIONS Socioeconomic differences in invasive cervical cancer could be partly explained by differences in the prevalence of HPV DNA and by a lower use of preventive care.
Collapse
Affiliation(s)
- S de Sanjosé
- Servei d'Epidemiologia i Registre del Càncer, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjosé S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Walboomers JM, Shah KV. Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 1996; 23:504-10. [PMID: 8946637 DOI: 10.1097/00007435-199611000-00012] [Citation(s) in RCA: 87] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
BACKGROUND AND OBJECTIVES Strong epidemiologic evidence indicates that human papillomavirus (HPV) is the main etiologic factor of cervical cancer. A few cohort studies suggest that most HPV infections are transient in young women and that persistent HPV infections are more common in older women. Little is known about the determinants of persistent HPV infections. The present study was aimed at increasing our knowledge about these determinants. GOALS To identify risk factors for genital HPV DNA detection among cytologically normal middle-aged women. STUDY DESIGN Eight hundred ten women who participated as control subjects in three case-control studies on cervical cancer in Spain, Colombia, and Brazil were included in this study. After an interview, women underwent a gynecologic examination with collection of exfoliated cells for a Papanicolaou smear and HPV DNA detection. Human papilloma virus DNA was detected by polymerase chain reaction (PCR)-based hybridization techniques. RESULTS The HPV positivity rate was 10.5% in the whole population, but was higher in the areas with high incidence of cervical cancer (17% in Brazil and 13% in Colombia) than in Spain (4.9%), which is a low-risk area for cervical cancer. Age was related to the prevalence of HPV DNA in Brazil, but not in Spain and Colombia. In univariate analyses in all three countries, the prevalence of HPV DNA was positively associated with the number of lifetime sexual partners and inversely associated with the levels of family income and with age at first sexual intercourse. There was four times increase in the odds ratio (OR) of HPV infection in women who had six or more lifetime sexual partners compared with those with one or less. The use of any kind of contraceptive tended to decrease the OR for HPV detection. Their ORs ranged from 0.44 (barrier methods) to 0.48 (oral contraceptives). In Spain and Colombia, antibodies against Chlamydia trachomatis were positively associated with the prevalence of HPV DNA. In a final multivariate model, the positive associations with lifetime number of sexual partners, socioeconomic status, and C. trachomatis persisted. CONCLUSIONS These results support the sexual transmission of HPV and suggest that socioeconomic status and antibodies to C. trachomatis are independent predictors of HPV detection in middle-aged cytologically normal women.
Collapse
Affiliation(s)
- N Muñoz
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghaffari AM, González LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88:1060-7. [PMID: 8683637 DOI: 10.1093/jnci/88.15.1060] [Citation(s) in RCA: 169] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND It is now established that certain types of human papillomaviruses (HPVs) are the sexually transmitted agents etiologically linked to cervical cancer. Studies assessing the contribution of the male's sexual behavior and genital HPV DNA status to the risk of development of cervical neoplasia in sexual partners have yielded inconsistent results. PURPOSE This study evaluates the role of men's sexual behavior and the presence of HPV DNA in the penis on the development of cervical cancer in their sexual partners in Spain, a low-risk area for cervical neoplasia. METHODS Husbands (n = 633) of women participating in two case-control studies of cervical neoplasia were interviewed to obtain information on lifestyle habits, including sexual practices. Cytologic samples were taken from the distal urethra and the surface of the glans penis of 183 husbands of case women and of 171 husbands of control women. These samples were analyzed by a polymerase chain reaction-based system using a generic probe and 25 type-specific probes for the detection and typing of HPV DNA. Serologic specimens were also obtained and analyzed for antibodies to Chlamydia trachomatis, Treponema pallidum, herpes simplex virus type II, and Neisseria gonorrhoeae. RESULTS The presence of HPV DNA in the husbands' penis conveyed a fivefold risk of cervical cancer to their wives (adjusted odds ratio [OR] for HPV DNA positivity = 4.9; 95% confidence interval [CI] = 1.9-12.6). The risk of cervical cancer was strongly related to HPV type (adjusted OR for HPV type 16 = 9.0; 95% CI = 1.1-77.5), to the husbands' number of extramarital partners (adjusted OR = 11.0; 95% CI = 3.0-40.0; for > or = 21 women versus one), and to the number of prostitutes as extramarital sexual partners (adjusted OR = 8.0; 95% CI = 2.9-22.2; for > or = 10 women versus none). Presence of antibodies to C. trachomatis (adjusted OR = 2.6; 95% CI = 1.4-4.6) and an early age at first sexual intercourse of the husband (adjusted OR = 3.2; 95% CI = 1.7-5.9; for < or = 15 years versus > or = 21 years) were also associated with cervical neoplasia in the wife. After adjustment for these variables and for the wife's pack-years of smoking, the husband's smoking was moderately associated with cervical cancer in his wife (adjusted OR = 2.5; 95% CI = 1.4-4.4; for > or = 26.2 pack-years versus none). CONCLUSIONS The study supports the role of men as vectors of the HPV types that are related to cervical cancer. Life-time number of female sexual partners, number of female prostitutes as sexual partners, and detection of HPV DNA in the penis of husbands are all surrogate markers of exposure to HPV during marriage. IMPLICATIONS Men who report multiple sexual partners or who are carriers of HPV DNA may be vectors of high-risk HPV types and may place their wives at high risk of developing cervical cancer. Prostitutes are an important reservoir of high-risk HPVs.
Collapse
Affiliation(s)
- F X Bosch
- Servei d'Epidemiologia i Registre del Càncer, L'Hospitalet de Llobregat, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
De Sanjosé S, Hamsíková E, Muñoz N, Bosch FX, Hofmannová V, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Muñoz MT, Ascunce N, Tafur L, Shah KV, Vonka V. Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia. Int J Cancer 1996; 66:70-4. [PMID: 8608970 DOI: 10.1002/(sici)1097-0215(19960328)66:1<70::aid-ijc13>3.0.co;2-f] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
This study evaluates the association of antibodies against HPV-16-derived peptides with cervical cancer and estimates the sensitivity and specificity of the serological assays in relation to HPV DNA detection in cervical cells by PCR. Study subjects were derived from 4 case-control studies carried out in Spain and Colombia. Sera from 544 cases of CIN III and invasive cancer and of 543 age-matched controls were tested for antibodies to 5 peptides derived from E2, E7 (3 partially overlapping frames of HPV 16 denoted E7/ 1, E7/2, E7/3) and L2 open reading frames of HPV 16. HPV DNA was detected using a L1-PCR based method. Among cancer controls, antibody response to E2 and E7/1, E7/2, E7/3 was higher in Colombia (22.5%,7.2%,11.7%,12.6% respectively) than in Spain (17.1 %, 4.7%, 5.9%, 5.9%). E7 antibodies were related to stage, particularly in CIN III vs. invasive stages and less markedly within invasive stages. Detection of antibodies to the E7/1 was associated to CIN III (OR = 1.8). The risk of invasive cervical cancer was increased among those with antibodies to E2 (OR = 2.2), to E7/1 (OR = 4.2), to E7/2 (OR = 4.3), and to E7/3 (OR = 2.5). Presence of antibodies to all the 3 E7 peptides increased the risk of CIN III (OR = 5.6) and that of invasive cancer (OR = 17.5). High levels of antibodies to E7/1 or E7/2 or E7/3 increased the risk of invasive cervical cancer (OR for high levels of antibodies vs. negatives to E7/1 OR = 22.6; E7/2 OR = 7.5, E7/3 OR = 3.4). In the present analysis, antibodies to L2 were not associated with either CIN III or cervical cancer. Serological markers of HPV 16 detected less than half of the HPV-16-DNA-positive cases. It is concluded that antibodies to E2 and particularly E7 antigens are strongly associated with cervical cancer. Antibodies to E7 seem to be a moderate marker of tumor burden.
Collapse
Affiliation(s)
- S De Sanjosé
- Servei d'Epidemiologia i Registre del Càncer, Institut Catalá d Oncologia, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
Historical analysis suggests that the decline and fall of the will was due not to any major piece of empirical work demonstrating that the concept was unsound but to general changes in philosophical fashion, and to the temporary influence of the anti-mentalistic tenets of behaviorism and the anti-volitional assumptions of psychoanalysis. Clinical disorders like abulia and impulsiveness share conceptual features that 19th-century alienists captured well in their clinical category of disorder of the will. Current accounts, which include semi-explanatory concepts such as "drive", "motivation" or frontal lobe "executive" are not conceptually better than the old notion of will nor are they superior as correlational variables for neurobiological studies. It is suggested that the will, updated according to modern work in the philosophy of action, be re-adopted as a research category in current psychiatry.
Collapse
Affiliation(s)
- G E Berrios
- Department of Psychiatry, University of Cambridge, United Kingdom
| | | |
Collapse
|
31
|
Moreno V, Muñoz N, Bosch FX, de Sanjosé S, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Navarro C, Vergara A. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:459-67. [PMID: 7549800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Data from four case-control studies on invasive cervical cancer and on cervical intraepithelial neoplasia grade III (CIN III) that were concurrently conducted in Spain and Colombia were used to look for factors that might favor the progression from CIN III to the invasive stage. These studies were compared in two ways; a case-case comparison and an estimation of the ratio of odds ratios with the use of of special logistic regression model that took into account the different design of each study and possible confounding factors. Variables studied were human papillomavirus status, viral load, viral types, sexual behavior, sexually transmitted diseases, reproductive patterns, oral contraceptives, and smoking. Both CIN III and invasive cervical cancer have a very similar profile of risk factors and none of them was different in a consistent way to suggest a role in the progression from CIN III to invasive cervical cancer. Some methodological problems such as cohort-specific differences and some selection biases could be adjusted for with a careful statistical analysis. Other problems derived from the cross-sectional nature of the design are unavoidable and should be considered in the interpretation of the results.
Collapse
Affiliation(s)
- V Moreno
- Servei d'Epidemiologia i Registre del Càncer, Hospital Duran i Reynals, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Raymond A, Müller W, Gens R, Gili M, Morales A, Yates A. Inventory and characterization of important radionuclides for the safety of storage and disposal. Correlation with key radionuclides in typical waste streams. J Radioanal Nucl Chem 1995. [DOI: 10.1007/bf02039895] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Muñoz N, Kato I, Bosch FX, De Sanjosé S, Sundquist VA, Izarzugaza I, Gonzalez LC, Tafur L, Gili M, Viladiu P. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes. Int J Cancer 1995; 60:438-42. [PMID: 7829255 DOI: 10.1002/ijc.2910600403] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Two case-control studies, including 449 histologically confirmed cases of cervical intra-epithelial neoplasia (CIN) III and 425 controls, and 2 studies on invasive cervical cancer, involving 316 histologically confirmed cases and 330 population controls, were conducted in Colombia and Spain to assess the role of herpes simplex virus type 2 (HSV-2) in cervical neoplasia. Antibodies to this virus were also measured in the sera of 931 husbands of cases and controls. A serological assay using type-specific antigens, glycoprotein C for type I (gC-I) and glycoprotein G for type 2 (gG-2) was employed. Immunoglobulin-G (IgG) sub-classes, IgG1 and IgG3, were measured in women positive for HSV-2 antibodies. No increase in risk of CIN III or invasive cancer was found in women whose sera or whose husbands' sera were positive to HSV-2. However, compared with women negative to HSV-2, the risk of CIN III progressively increased with increasing levels of IgG1. The trend was statistically significant in Colombia. There was also a statistically significant increasing trend in risk of invasive cancer with levels of IgG1 in Spain. The levels of IgG3 and its ratio to IgG1, which may indicate recurrent infections, were not associated with the risk of either type of cancer. When the association with IgG1 was analyzed by human papillomavirus (HPV) DNA status, as determined by polymerase chain reaction, the trend was clearer in women whose HPV status was not determined or in those with negative HPV DNA. These results suggest that the role of HSV-2 is merely marginal and do not support the hypothesis that recurrent HSV-2 infections are of importance for cervical neoplasia.
Collapse
Affiliation(s)
- N Muñoz
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
de Sanjosé S, Muñoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, González LC, Tafur L, Gili M. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994; 56:358-63. [PMID: 8314322 DOI: 10.1002/ijc.2910560311] [Citation(s) in RCA: 71] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Case-control studies of cervical intra-epithelial neoplasia grade III (CIN III) and of invasive cervical cancer were carried out in Spain and Colombia to assess the relationship between cervical cancer and 6 common sexually transmitted agents (STAs). The CIN-III studies included 525 cases and 512 controls matched for age and for the place of recruitment; the invasive-cancer studies included 373 histologically confirmed cases of squamous-cell carcinoma and 387 age-stratified controls selected randomly from the populations that generated the cases. Antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, herpes simplex virus type II (HSV-2) and cytomegalovirus (CMV) were tested in 88% of the women. Cervical scrapes were examined for HPV DNA in 63% of the women using a polymerase-chain-reaction assay (PCR). Among controls, the highest antibody prevalence was to CMV (96.5%), followed by HSV-2 (31.4%) and C. trachomatis (23.3%). For all STAs, the sero-prevalence was markedly higher in Colombia than in Spain both for cases and for controls. After adjustment for the presence of HPV DNA, C. trachomatis was the only STA associated with CIN III in both countries; Spain and Colombia. In both countries, the risk of CIN III increased with increasing of C. trachomatis antibody titers. Among Spanish women, an increase in risk of invasive carcinoma was found for those with antibodies to N. gonorrhoeae; those with antibodies to HSV-2 and those with antibodies to C. trachomatis. These associations were present only in HPV-DNA-negative women. Among HPV-DNA-positive women, none of the STAs considered were associated with cervical neoplasia. Our findings could be interpreted as indicating that past infections with HSV-2, N. gonorrhoeae and C. trachomatis are surrogate markers of HPV, but because HPV DNA may have escaped detection, we cannot exclude that these STAs are also of separate etiological significance.
Collapse
Affiliation(s)
- S de Sanjosé
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Muñoz N, Bosch FX, de Sanjosé S, Viladiu P, Tormo J, Moreo P, Ascunce N, González LC, Tafur L, Gili M. [Human papilloma virus in the etiology of cervicouterine cancer]. Bol Oficina Sanit Panam 1993; 115:301-9. [PMID: 8240700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The objectives of this study were to confirm the hypothesis that invasive carcinoma of the uterine cervix and the precursors of that condition are most often caused by human papilloma virus (HPV) infections, and to determine whether or not other risk factors are involved in the neoplastic process. For this purpose, four concurrent case-control studies were carried out. Two included cases of invasive cervical cancer and population-based controls. The other two included cases of in situ carcinoma and controls. Research was carried out in nine provinces of Spain and in Cali, Colombia. The identification of cases took place between June 1985 and June 1988. The studies included 436 incident cases of invasive carcinoma and 387 controls, selected at random from the corresponding populations, and 525 cases of in situ carcinoma and 512 controls paired by age, place of recruitment, and date that cytological specimens were taken from the women participating in cytological screening programs. Exposure to HPV was detected through hybridization tests after amplification by polymerase chain reaction (PCR) in exfoliated cervical cells from cases and controls. Exposure to HPV was the principal risk factor in the four studies. For invasive carcinoma, the relative risk and 95% confidence interval were 46.2 (18.5-115.1) in Spain and 15.6 (6.9-34.7) in Colombia. For in situ carcinoma, the figures were 56.9 (24.8-130.6) in Spain and 15.5 (8.2-29.4) in Colombia. This strong association was specific for types 16, 18, 31, 33, and 35 as well as still-unclassified HPV types.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- N Muñoz
- Unidad de Estudios de Campo y de Intervenciones, Centro Internacional de Investigaciones sobre el Cáncer, Lyon, Francia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Muñoz N, Bosch FX, de Sanjosé S, Vergara A, del Moral A, Muñoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:423-31. [PMID: 8220086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
A case-control study of 525 histologically confirmed cases of cervical intraepithelial neoplasia grade III and 512 controls was done in Spain and Colombia to assess the role of various risk factors taking into account the effect of human papillomavirus (HPV). The presence of HPV DNA, assessed by a polymerase chain reaction-based method, was the strongest risk factor identified. In Spain the adjusted odds ratio (OR) and 95% confidence interval (CI) (numbers in parentheses) were 56.9 (24.8-130.6) and, in Colombia, were 15.5 (8.2-29.4). In addition to HPV, the multivariate analysis revealed independent effects of early age at first intercourse (in Spain ORa, 4.3; 95% CI, 2.0-9.3 for ages < 17 versus 20+ years and in Colombia ORa, 9.0; 95% CI, 2.6-30.9 for ages < 14 versus 20+ years), and antibodies to Chlamydia trachomatis (in Spain ORa, 2.3; 95% CI, 1.1-4.5; and in Colombia ORa, 1.7; 95% CI, 1.1-2.7). High parity showed a significant effect only in Colombia (ORa, 2.0; 95% CI, 1.0-5.0 for > or = 6 versus 1) while number of partners of the woman and specially of her husband showed a strong effect in Spain only (ORa, 6.9; 95% CI, 3.1-15.3 for partners of the husband > or = 21 versus 1-5). Smoking and use of oral contraceptives did not show significant or consistent associations. Among HPV-DNA positive women early age at first intercourse and high parity increased the risk of cervical intraepithelial neoplasia III but the effect was statistically significant only for the former.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- N Muñoz
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Bosch FX, Muñoz N, de Sanjosé S, Navarro C, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Gili M, Larrañaga I. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:415-22. [PMID: 8220085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
A case-control study of 525 cases of cervical intraepithelial neoplasia grade III (CIN III) and 512 controls was conducted in Spain and Colombia between 1985 and 1988 to assess the role of human papillomavirus (HPV) in the etiology of CIN III. HPV DNA in cytological scrapes from the cervix was assessed by Virapap and by polymerase chain reaction (PCR) based on the L1 consensus primers. A subsample of 268 specimens was also tested for HPV DNA using Southern hybridization. In Spain, the PCR-based prevalences of HPV DNA were 70.7% among cases and 4.7% among controls. Odds ratio (OR) and 95% confidence interval (numbers in parentheses) for HPV DNA were 56.9 (24.8-130.6). In Columbia HPV DNA was detected by PCR in 63.2% of the cases and in 10.5% of the controls. The OR was 15.5 (8.2-29.4). The estimated fractions of CIN III attributable to HPV were 72.4% in Spain and 60.3% in Colombia. HPV 16 was the predominant viral type and showed the strongest association with CIN III; in Spain the OR was 295.5 (44.8-1946.4) and in Colombia the OR was 27.1 (10.6-69.5). HPV DNA of unknown type was frequent in HPV-positive cases (18.3% in Spain and 38.0% in Colombia) and controls (66.7% in Spain and 47.4% in Colombia). The comparison of results from Virapap and PCR indicated that PCR is the method of choice for epidemiological studies. These data strongly support the hypothesis of the viral origin of CIN III, the common etiology of CIN III and invasive cervical cancer, and the causal nature of the association between HPV and CIN III.
Collapse
Affiliation(s)
- F X Bosch
- International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Sorba G, Di Stilo A, Gasco AM, Gili M, Gasco A, Orsetti M. Synthesis and H2-antagonist properties of some 1,2,5-thiadiazole-1-oxide derivatives. Farmaco 1992; 47:1445-55. [PMID: 1363461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
Abstract
A series of 1,2,5-thiadiazole-1-oxide derivatives has been synthesized and studied for its H2-antagonist properties. These derivatives can be considered derived from classical H2-antagonists in which the structure was deeply modified in order to evidence the minimal structural requirements for the activity. It was found that it is sufficient to have the 1,2,5-thiadiazole-1-oxide ring substituted with an alkylamino moiety and with an aliphatic chain linked to the hydroxy or ether group to achieve compounds as active as cimetidine. A few considerations on the binding on guinea-pig cerebral cortex of a series of H2-antagonists with more and more simplified structures are also reported.
Collapse
Affiliation(s)
- G Sorba
- Dipartimento di Scienza e Technologia del Farmaco, Torino
| | | | | | | | | | | |
Collapse
|
39
|
Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52:743-9. [PMID: 1330933 DOI: 10.1002/ijc.2910520513] [Citation(s) in RCA: 369] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
To evaluate the association between human papillomavirus (HPV) and cervical cancer, we performed a population-based case-control study in Columbia and Spain, the former country having an incidence rate of cervical cancer about 8 times higher than the latter. It included 436 cases of histologically confirmed invasive cervical cancer and 387 randomly selected population controls. Information on demographic variables, sexual behaviour and other risk factors was obtained by interview. HPV-DNA was measured in cervical-swab specimens with 3 hybridization assays: ViraPap, Southern hybridization (SH) and polymerase chain reaction (PCR). The presence of HPV-DNA and detection of types 16, 18, 31, 33 and 35 were strongly associated with cervical cancer in each country regardless of the assay used. For both countries combined the adjusted odds ratios and 95% confidence intervals were: ViraPap OR = 25.9 (10.0-66.7); SH OR = 6.8 (3.4-13.4); and PCR OR = 28.8 (15.7-52.6). HPV-16 was the most common type detected in both cases and controls. Our results indicate that there is a very strong association between HPV 16, 18, 31, 33 and 35 and invasive cervical cancer and that this association is probably causal.
Collapse
Affiliation(s)
- N Muñoz
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Bosch FX, Muñoz N, de Sanjosé S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52:750-8. [PMID: 1330934 DOI: 10.1002/ijc.2910520514] [Citation(s) in RCA: 148] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
A population-based case-control study of cervical cancer was conducted in Spain and Colombia to assess the relationship between cervical cancer and exposure to human papillomavirus (HPV), selected aspects of sexual and reproductive behaviour, use of oral contraceptives, screening practices and smoking. The study included 436 cases of histologically confirmed squamous-cell carcinoma and 387 age-stratified controls randomly selected from the general population that generated the cases. The presence of HPV DNA in cervical scrapes was assessed by PCR-based methods and was the strongest risk factor (OR = 23.8; 13.4-42.0). Risk estimates for any other factor were only slightly modified after adjusting for HPV status. Among women found positive for HPV DNA, only the use of oral contraceptives was a risk factor for cervical cancer (OR = 6.5; 1.3-31.4 for ever vs. never use). Patients with cervical cancer who were HPV DNA-negative retained most of the established epidemiological features of this disease. This suggests that some instances of HPV infection went undetected or that other sexually transmitted factor(s) contribute to the causation of cervical cancer. Early age at first intercourse (OR = 4.3; 2.1-9.0 for age < 16 vs. 24+) and early age at first birth (OR = 5.0; 1.8-14.2 for age < 16 vs. 24+) were associated with increased risk of cervical cancer; these effects were independent of one another. Low educational level was a risk factor (OR = 2.5; 1.6-3.9). Number of sexual partners was in our study a surrogate for HPV infection. Smoking and parity after age 24 were weakly and inconsistently associated with the risk of cervical cancer. Previous screening (OR = 0.7; 0.5-1.0) and ever having undergone a Caesarean section (OR = 0.4; 0.2-0.8) were protective factors.
Collapse
Affiliation(s)
- F X Bosch
- Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Guerrero E, Daniel RW, Bosch FX, Castellsagué X, Muñoz N, Gili M, Viladiu P, Navarro C, Zubiri ML, Ascunce N. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 1992; 30:2951-9. [PMID: 1333485 PMCID: PMC270559 DOI: 10.1128/jcm.30.11.2951-2959.1992] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
In order to provide a reliable diagnosis for the presence and type of human papillomavirus (HPV) DNA in a case-control study of cervical cancer in Colombia and Spain, 926 cervical scrapes from female subjects were examined by ViraPap (VP) and Southern hybridization (SH), and 510 of these (263 cases and 247 controls) were also tested by polymerase chain reaction (PCR) using the HPV L1 consensus primers. HPV DNA prevalence was much higher in cases than in controls by each of the three tests. There was complete agreement between the results of the three tests for 64.9% of the 510 specimens; 53.5% were negative and 11.4% were positive (regardless of type) by all tests. An additional 29.0% of the specimens were positive by PCR: 19.4% by PCR alone, 6.7% by PCR and VP, and 2.9% by PCR and SH. SH and/or VP gave positive results for 6.0% of the specimens for which the PCR finding was negative: 2.7% by SH alone, 2.5% by VP alone, and 0.8% by both VP and SH. When specimens which were positive by VP alone or only by SH at low-stringency conditions were excluded, PCR confirmed all but four specimens which were positive by other tests. The concordance between type-specific diagnosis by SH and PCR was 86% when HPVs were typed in both tests. HPV-16 accounted for over 80% of the typed HPVs in each test. The presence of blood in case specimens did not appear to inhibit HPV positivity by VP or by PCR at the dilution tested. Low amounts of cellular DNA of specimens resulted in some underestimation of HPV positivity by VP and SH but not by PCR. Compared with that of PCR, the sensitivities for case specimens were 38% by SH and 50% by VP; the sensitivity for control specimens, although it could not be measured precisely because there were few positive specimens, appeared to be lower than for case specimens. It was concluded that PCR-based tests are best suited for epidemiological investigation of HPVs.
Collapse
|
42
|
Cobos Gil MA, Rada I, Gili M, Camacho I, Asín E, Yuste P. [A simplified method for estimating mitral valve area by Doppler]. Arch Inst Cardiol Mex 1991; 61:339-44. [PMID: 1953210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Based upon geometrical considerations we have developed a new method for estimation of valve area in patients with mitral stenosis. A special ruler enables us to read the valve area from the Doppler record. We prove that our new method is more precise and rapid than original Hatle's procedure. In 35 patients, we found a good correlation between the result of our method and the valve area obtained by 2D-Echo. Thus the new method is very useful for Doppler evaluation of mitral stenosis patients.
Collapse
Affiliation(s)
- M A Cobos Gil
- Servicio de Cardiología del Hospital Ramón y Cajal, Madrid
| | | | | | | | | | | |
Collapse
|
43
|
Gili M, Zunzunegui MV, Vilches A. [Confounding bias. Interaction]. Enferm Infecc Microbiol Clin 1990; 8:647-53. [PMID: 2098126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Gili
- Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Sevilla
| | | | | |
Collapse
|
44
|
Cayuela Domínguez A, Lacalle Remigio JR, Gili M. [Interprovincial variations in mortality from cancer: factorial and cluster analyses]. Gac Sanit 1990; 4:227-32. [PMID: 2086531 DOI: 10.1016/s0213-9111(90)71038-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Cancer mortality rates among males, for sixteen sites in the fifty Spanish provinces were analyzed using two data reduction techniques, factor and cluster analysis. Five independent underlying factors were identified by factor analysis which appear to influence cancer mortality patterns. Cluster analysis aggregated provinces into different groups using these factor scores as the clustering criteria. Each of the groups thus defined a distinctive profile of site-specific cancer mortality rates.
Collapse
Affiliation(s)
- A Cayuela Domínguez
- Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Alicante
| | | | | |
Collapse
|
45
|
Falasca CA, Gili M, Grana D, Gomez E, Zoppi J, Mareso E. Chronic myocardial damage in experimental T. cruzi infection of a New World primate, Cebus sp. monkey. Rev Inst Med Trop Sao Paulo 1990; 32:151-61. [PMID: 2135367 DOI: 10.1590/s0036-46651990000300002] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Eighteen Cebus apella monkeys, (juvenile and adult of both sexes) were inoculated five years ago, with three Trypanosoma cruzi strains (CA1, n = 10; Colombian, n = 4 and Tulahuen, n = 4), either by conjunctival or intraperitoneal route, once or repeatedly. Parasitological, hematological, serological, enzymatic, radiographic, electro and echocardiographic findings have been previously published and they are similar to those observed in human pathology. The most frequent electrocardiographic alteration was right branch bundle block. Six animals, chosen at random, were sacrificed. Those sacrificed 20 to 25 months post-first inoculation showed focal accumuli of leukocytes with myocytolysis. Foci of diffuse interstitial fibrosis with mild infiltrate of leukocytes among fibers were observed in the animals sacrificed 36 to 47 months post-inoculation. No parasites were seen. The lesions were more prominent in the ventricular walls and the septum. The fact that the infiltrates were predominant in the animals sacrificed at a shorter time after first inoculation and that fibrosis was more severe in those sacrificed at a longer time suggests that there is a progression of the infiltrative lesions to fibrosis, with a leukocytic activity indicative of a chronic phase. These lesions are similar to those described in human chronic Chagas' disease. This would demonstrate that this model is useful in evaluating a progress in the knowledge of the pathogenesis which is still a controversial issue, immunology, immunogenesis and chemotherapeutic agents of the chronic and indeterminate phases of this disease.
Collapse
Affiliation(s)
- C A Falasca
- Instituto Latinoamericano de Investigaciones Medicas Universidad del Salvador (ILAIMUS), Buenos Aires, Argentina
| | | | | | | | | | | |
Collapse
|
46
|
Gili M, Carrasco M, Sentís J. [Information bias]. Enferm Infecc Microbiol Clin 1990; 8:242-6. [PMID: 2090213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Gili
- Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Sevilla
| | | | | |
Collapse
|
47
|
Gili M, Cayuela A. [Selection bias]. Enferm Infecc Microbiol Clin 1990; 8:176-81. [PMID: 2094391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Gili
- Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Sevilla
| | | |
Collapse
|
48
|
Gili M, Donado J, Hernández I. [Screening]. Enferm Infecc Microbiol Clin 1990; 8:108-15. [PMID: 2098135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Gili
- Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Sevilla
| | | | | |
Collapse
|
49
|
Gili M, Lacalle JR, Velasco A. [Experimental studies]. Enferm Infecc Microbiol Clin 1990; 8:52-7. [PMID: 2095906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Gili
- Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Sevilla
| | | | | |
Collapse
|
50
|
Gili M, Martínez-Cañabate E, Nieto C. [Case-control studies. Transversal studies]. Enferm Infecc Microbiol Clin 1989; 7:559-63. [PMID: 2490435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|